Browse
Explore conditions, clinical trials, and the organisations running them.
Never miss a new study
Get alerted when new trials match your condition
Sign up free to track the conditions you care about and get a personal digest when new trials appear.
By submitting, you agree to our Terms of use
127005 trials found · Page 736 of 6351
-
Could a heart MRI replace invasive scans for some heart attacks?
Diagnosis Recruiting nowPatients with a suspected myocardial infarction are subdivided into ST-elevation and non-ST-elevation myocardial infarctions (STEMI and NSTEMI, respectively) using ECG. While patients with STEMI are urgently referred to a cath lab, patients with NSTEMI usually undergo a planned i…
Sponsor: Region Stockholm • Aim: Diagnosis
Last updated Aug 14, 2026 00:00 UTC
-
Experimental combo therapy targets Hard-to-Treat pancreatic cancer
Disease control Recruiting nowThis is a phase I study of an agonistic CD40 antibody (mitazalimab) injected intratumorally at the time of surgical IRE in patients with locally advanced pancreatic cancer. Intratumoral delivery has potential to be more effective than systemic (intravenous) delivery while decreas…
Phase 1 • Sponsor: University of California, San Diego • Aim: Disease control
Last updated Jun 27, 2026 14:02 UTC
-
New shot aims to stop devastating NMOSD Flare-Ups
Disease control Recruiting nowTo evaluate the efficacy and safety of B001 injection in aquaporin-4 antibody positive patients with neuromyelitis optica spectrum disorder.
Phase 2/3 • Sponsor: Shanghai Jiaolian Drug Research and Development Co., Ltd • Aim: Disease control
Last updated Jun 27, 2026 12:29 UTC
-
New pill could tame rare blood disorder without chemotherapy
Disease control OngoingThe purpose of this study is to evaluate the efficacy and safety of bomedemstat compared with hydroxyurea in cytoreductive therapy naïve essential thrombocythemia (ET) participants for whom cytoreductive therapy is indicated. Its primary objective is to compare bomedemstat to hyd…
Phase 3 • Sponsor: Merck Sharp & Dohme LLC • Aim: Disease control
Last updated Aug 29, 2026 00:00 UTC
-
Could a Three-Drug cocktail save more cardiac arrest patients?
Disease control Recruiting nowThis project is a randomized controlled clinical research design, The hypothesis P-I-C-O of the study is: For adult patients in the Taipei City and New Taipei City communities who have suffered sudden non-traumatic death and have been resuscitated by advanced paramedics, the inte…
Sponsor: National Taiwan University Hospital • Aim: Disease control
Last updated Jun 27, 2026 07:57 UTC
-
New drug combo offers hope for elderly lymphoma patients too frail for chemo
Disease control Recruiting nowThe study will measure the safety, tolerability, and efficacy with acalabrutinib in combination with rituximab in treatment-naïve elderly and/or frail patients with diffuse large B-cell lymphoma (DLBCL), who are otherwise unsuitable for standard front line chemoimmunotherapy trea…
Phase 2 • Sponsor: AstraZeneca • Aim: Disease control
Last updated Sep 06, 2026 00:00 UTC
-
New drug cocktail aims to wipe out lung cancer before surgery
Disease control OngoingThis study is researching an experimental drug called fianlimab (also called REGN3767) with two other medications called cemiplimab and platinum-doublet chemotherapy, individually called a "study drug" or collectively called "study drugs", when combined in this study. The study i…
Phase 2 • Sponsor: Regeneron Pharmaceuticals • Aim: Disease control
Last updated Aug 12, 2026 00:00 UTC
-
Could a common gout drug protect hearts from myocarditis?
Disease control Recruiting nowMyocarditis is an inflammatory disease of the heart, mostly caused by viruses. Patients with acute myocarditis are exposed to several complications: recurrence, ventricular arrhythmias (from 5 to 30%), heart failure (5-10%), death or heart transplantation (\< 4%). To date, there …
Phase 3 • Sponsor: Assistance Publique - Hôpitaux de Paris • Aim: Disease control
Last updated Jun 27, 2026 09:08 UTC
-
Placental grafts may speed healing of stubborn diabetic foot sores
Disease control Recruiting nowThe purpose of this study is to evaluate the efficacy of four dehydrated complete human placental membrane, also defined as Cellular, Acellular, Matrix-like Products/skin substitutes, plus SOC versus SOC alone in achieving complete closure of hard-to-heal diabetic foot ulcers ove…
Sponsor: StimLabs • Aim: Disease control
Last updated Jun 27, 2026 09:10 UTC
-
New hope for rare cancers: immunotherapy drug targets tumors regardless of origin
Disease control Recruiting nowThe ANTARES study is a phase II basket trial designed to evaluate the tissue-agnostic efficacy of the monoclonal anti-PD1 antibody, nivolumab, in patients with advanced or metastatic rare tumors. The study aims to treat rare malignancies with PD-L1 expression (CPS ≥ 10), regardl…
Phase 2 • Sponsor: Instituto do Cancer do Estado de São Paulo • Aim: Disease control
Last updated Jun 27, 2026 12:08 UTC
-
Can a massive natural history study unlock the secrets of rare movement disorders?
Knowledge-focused Recruiting nowAtaxias, hereditary spastic paraplegias (HSP), and spastic ataxias (collectively referred to as SPAX diseases) are rare neurological conditions that cause progressive problems with walking, balance, coordination, and daily activities. Although many SPAX diseases are caused by spe…
Sponsor: Heidelberg University • Aim: Knowledge-focused
Last updated Sep 03, 2026 00:00 UTC
-
Drug cocktail may help radioactive iodine work better in tough thyroid cancers
Disease control Recruiting nowThis phase II trial tests how well vemurafenib and cobimetinib work in treating patients with high risk differentiated thyroid carcinoma with BRAFV600E mutation, in preparation for radioactive iodine therapy. Vemurafenib and cobimetinib are used in patients whose cancer has a mut…
Phase 2 • Sponsor: City of Hope Medical Center • Aim: Disease control
Last updated Jun 27, 2026 09:01 UTC
-
One shot for two viruses: new combo vaccine trial shows promise
Vaccine CompletedThe purpose of this study is to evaluate the safety, reactogenicity, and immunogenicity in relation to the product attributes of mRNA-1083 vaccine when administered as a single intramuscular (IM) injection in adults ≥50 to \<65 years of age.
Phase 2 • Sponsor: ModernaTX, Inc. • Aim: Vaccine
Last updated Jun 27, 2026 07:54 UTC
-
Hormone boost may shield soldiers from training injuries
Prevention Recruiting nowNon-combat-related muscle, tendon and bone injuries are the most common injuries suffered by military personnel, particularly in new recruits. These injuries impact military readiness and are responsible for roughly 60% of limited duty days, 65% of soldiers who are unable to depl…
Phase 4 • Sponsor: Bradley Nindl • Aim: Prevention
Last updated Aug 20, 2026 00:00 UTC
-
Radiation and immunotherapy combo shows promise for advanced nasopharyngeal cancer
Disease control Recruiting nowThis is a prospective, single-arm, phase II clinical trial. The purpose of this study is to evaluate the efficacy and adverse effect of SBRT and LDRT combined with programmed death 1 (PD-1) antibody and chemotherapy in recurrent/metastatic nasopharyngeal carcinoma patients.
Phase 2 • Sponsor: Sun Yat-sen University • Aim: Disease control
Last updated Jun 27, 2026 12:32 UTC
-
Can adding social support to trauma therapy ease PTSD in youth?
Symptom relief Recruiting nowResilient Roots is integrated into the TRANSFORM Center to promote translation of research findings into clinical interventions, to inform the next generation of research on child abuse and neglect (CAN), and to facilitate dissemination of research and practice knowledge/skills t…
Sponsor: University of Rochester • Aim: Symptom relief
Last updated Sep 05, 2026 00:00 UTC
-
Could antibiotics save malnourished kids after hospital?
Disease control CompletedMalnutrition underlies 45% of child deaths, and has far-reaching educational, economic and health consequences. Severe acute malnutrition (SAM) affects 17 million children globally and is the most life-threatening form of malnutrition. Community-based management of acute malnutri…
Phase 3 • Sponsor: Queen Mary University of London • Aim: Disease control
Last updated Aug 27, 2026 00:00 UTC
-
New antibody could block malaria transmission in High-Risk areas
Disease control CompletedMali faces a significant challenge with malaria, particularly among its younger population. While existing measures like seasonal chemoprevention and vaccination have shown efficacy, further innovations are necessary to combat this disease. The monoclonal antibody TB31F shows pro…
Phase 1/2 • Sponsor: Radboud University Medical Center • Aim: Disease control
Last updated Jun 27, 2026 08:12 UTC
-
New drug shows promise for fatty liver cirrhosis in early trial
Disease control OngoingResearchers are looking for ways to treat a type of liver disease caused by elevated liver fat, called metabolic dysfunction-associated steatohepatitis (MASH). MASH was formerly called non-alcoholic steatohepatitis (NASH). Researchers want to learn if a study medicine called efin…
Phase 2 • Sponsor: Merck Sharp & Dohme LLC • Aim: Disease control
Last updated Jun 27, 2026 09:09 UTC
-
Donor vaccine aims to shield transplant patients from common virus
Prevention Recruiting nowThis phase II clinical trial tests how well the cytomegalovirus-modified vaccinica Ankara (CMV-MVA) Triplex vaccine given to human leukocyte antigens (HLA) matched related stem cell donors works to prevent cytomegalovirus (CMV) infection in patients undergoing hematopoietic stem …
Phase 2 • Sponsor: City of Hope Medical Center • Aim: Prevention
Last updated Jun 27, 2026 11:00 UTC